Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Retrospective Study on MR Imaging of ET and PD Patients Subjected With MRgFUS Thalamotomy
A retrospective study evaluating MRI findings in essential tremor and Parkinson's disease patients after MR-guided focused ultrasound thalam…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Clinical trial update indicates that the GentleCath Men intermittent catheter with FeelClean technology has completed its study, evaluating …
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of ND0612 delivered by continuous subcutaneous infusion in Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Subthalamic Nucleus Stimulation Electrode and Psychiatric Lesion Effects in Parkinson's Disease [NA]
A completed clinical trial evaluating subthalamic nucleus stimulation electrode effects and psychiatric lesions in Parkinson's disease. The …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease
A completed clinical trial evaluating diaphragmatic thickness and pulmonary function in Parkinson's disease patients. The study is sponsored…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa [Phase 2]
Phase 2, double-blind, placebo-controlled study evaluating the efficacy of 40 mg/day KW-6002 (istradefylline) added to levodopa/carbidopa in…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa [Phase 3]
A Phase 3 clinical trial evaluating istradefylline as an add-on therapy for Parkinson's disease in patients on levodopa has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers. [Phase 1]
Phase 1 study evaluating the impact of rifampin on the metabolism of the Parkinson's disease drug istradefylline in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy [Phase 2, Phase 3]
This update covers a long-term, safety study of KW-6002 (istradefylline) across a flexible dose range in Parkinson's disease patients with m…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa [Phase 2]
Phase 2 double-blind, placebo-controlled study of istradefylline at 20 and 60 mg/day in Parkinson's disease patients on levodopa/carbidopa h…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients [Phase 2]
This Phase 2 trial evaluated istradefylline (KW-6002) as monotherapy in Parkinson's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating the effect of continuous nocturnal apomorphine on sleep disturbances in Parkinson disease patients has com…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 [Phase 3]
This document announces an extension of the Phase 3 trial of istradefylline for Parkinson's disease in patients who completed prior studies.…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 3]
The Phase 3 trial investigating istradefylline for Parkinson's disease in patients taking levodopa has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease [Phase 3]
Clinical trial update announcing the completion of a Phase 3 study evaluating istradefylline (KW-6002) for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial evaluating intranasal insulin for motor and non-motor symptoms in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Biomarkers to Guide Directional DBS for Parkinson's Disease [NA]
This completed clinical trial evaluated biomarkers to guide directional deep brain stimulation for Parkinson's disease; results were posted …
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Kick Out Parkinson's Disease 2 [NA]
Completed clinical trial for Parkinson's disease with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Study of Parkinson's Early Stage With Deferiprone [Phase 2]
Phase 2 clinical trial of deferiprone in early-stage Parkinson's disease has completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Treatment of Chronic Constipation in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update on treating chronic constipation in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Overnight Switch From Rasagiline To Safinamide [Phase 4]
A Phase 4 clinical trial reports an overnight switch from rasagiline to safinamide in Parkinson disease, completed.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients [Phase 2]
Phase 2 trial comparing intermittent oral vs semi-continuous intra-oral administration of levodopa/carbidopa in Parkinson disease patients h…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Levodopa Benserazide Generic Formulation Versus the Originator [Phase 4]
A Phase 4 trial comparing a generic levodopa/benserazide formulation to the originator in Parkinson disease has been completed.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Cartesia eXTend 3D Study [NA]
A completed clinical trial update for the Cartesia eXTend 3D Study in Parkinson disease, with results posted on March 29, 2024, sponsored by…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa [Phase 3]
Phase 3 trial evaluating safinamide as add-on therapy to levodopa in idiopathic Parkinson's disease with motor fluctuations; study completed…